Sign in to follow
Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
June 17, 2014 |

U.S. Companies Ease Tax Load With Overseas Mergers

Takeovers by U.S. companies of targets in low-tax environments have doubled in proportion to all overseas deals.
5 minute read
May 28, 2014 |

Valeant Makes Skin Care Licensing Deal Amid Allergan Offer

Six Am Law 100 firms are advising as Valeant sells the licensing rights to several skin care products to Nestle for $1.4 billion as it ups its unsolicited bid for Botox maker Allergan.
5 minute read
May 15, 2014 |

Hedge Fund Activism: New Myths and Old Realities

In his Corporate Securities column, John C. Coffee Jr., the Adolf A. Berle Professor of Law at Columbia University Law School and Director of its Center on Corporate Governance, writes: Two recent developments have changed the playing field of corporate governance. In their wake, every pundit has announced that this is the heyday of hedge fund activism.
25 minute read
May 07, 2014 |

After the Merger, Merging Corporate Data

When two megacompanies merge, it is vital they figure out how to integrate their data and other information assets to avoid litigation and regulatory risks.
3 minute read
May 06, 2014 |

Four Firms Lead on Bayer's Big Merck Carve-Out

In the latest large pharmaceutical industry deal, Covington, Fried Frank, Morgan Lewis and Sullivan & Cromwell are advising on a $14.2 billion transaction between Merck and German drug giant Bayer.
7 minute read
April 29, 2014 |

Kirkland Advises Bristol-Myers Squibb on iPierian Buy

Bristol-Myers Squibb is paying up to $725 million for biotech firm iPierian.
2 minute read
April 28, 2014 |

Five Am Law Firms Advise on Forest Labs M&A Deals

Forest Laboratories is paying $1.46 billion for Furiex Pharmaceuticals while also selling Furiex's royalties on two products to Royalty Pharma for $415 million.
3 minute read
April 24, 2014 |

Firms Feast on Yet Another Health Care Deal

Medical device maker Zimmer Holdings has agreed to pay $13.35 billion to acquire rival Biomet Inc.
4 minute read
April 22, 2014 |

M&A Lawyers Line Up for Major Pharma Deals

Valeant launched a $45.7 billion hostile takeover bid for Botox-maker Allergan, while Novartis announced a series of transactions with GlaxoSmithKline and Eli Lilly.
7 minute read
February 21, 2014 |

Dealmaker of the Week: Latham's Charles Ruck

Ruck, along with fellow Orange County M&A partner R. Scott Shean, led the Latham team advising Actavis on its $25 billion acquisition of specialty pharmaceuticals company Forest Laboratories.
6 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Creating a Culture of Compliance

      Brought to you by Ironclad

      Download Now

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now